Blog
14 May, 2020
This chronic disease has an incidence of between 3 and 7% of the population in Spain, according to experts Treatments provide clear results in patients’ health […]
12 May, 2020
In just a few months, Spain has launched 64 clinical trials with potential anti-coronavirus drugs, ranking first in Europe and fourth in the world. The brutal […]
27 April, 2020
Farmaindustria participates in a Eupati webinar aimed at patients from all over Spain Explain how laboratories are working, in collaboration with researchers and hospitals, so that […]
21 April, 2020
Via: www.elglobal.es Clinical and industry experts carry out a decalogue with measures to strengthen the Spanish research system In recent years, Spain has positioned itself among […]
20 April, 2020
Via: www.immedicohospitalario.es Farmaindustria has collected in a document the measures that 120 experts from hospital centers and pharmaceutical companies propose to boost Spanish leadership and attract […]
18 March, 2020
Source: www.actasanitaria.com The Spanish Agency of Medicines and Health Products (AEMPS), as the competent national authority in the authorization of clinical trials, has proposed a series […]
9 March, 2020
The European employer of the innovative industry has its sights set on the roadmap of the Industrial Strategy for the sector, which will be published next […]
4 March, 2020
Source: www.expansion.com The pharmaceutical industry is positioned as a leading actor for the necessary evolution of the Spanish economy towards a productive model supported by innovation […]
24 February, 2020
Source: www.immedicohospitalario.es The clinical efficacy of this new diagnosed tool has been tested in five hospitals with clinical trials, which is a step towards personalized medicine […]
10 February, 2020
The expected return on investment in new medicines stands at 1.8%, the lowest point in the last 10 years, according to a Deloitte report On the […]
7 February, 2020
Source: www.immedicohospitalario.es The arrival of advanced therapies, such as CAR-T cells, immunotherapy or other targeted treatments and their incorporation into the assistance protocols are being able […]
6 February, 2020
Farmaindustria advocates strengthening the role of the Spanish Agency for Medicines and Health Products (Aemps) to maintain the competitiveness of our country in biomedical R&D The […]
